News - UF Innovate

Atsena Therapeutics Receives FDA Clearance of an Investigational Gene Therapy for X-Linked Retinoschisis

The U.S. Food and Drug Administration (FDA) has cleared Atsena Therapeutics' Investigational New Drug (IND) application for a Phase I/II clinical trial of ATSN-201 in patients with X-linked retinoschisis (XLRS). Atsena Therapeutics is a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness.

For the 2nd Year in a Row, Admiral Makes the Inc. 5000

Inc. revealed today that UF Accelerate client resident Admiral, The Visitor Relationship Management (VRM) Company, was named for a second year in a row to the 2023 Inc. 5000, its annual list of the fastest-growing private companies in America. The prestigious ranking provides a data-driven look at the most successful companies within the economy’s most dynamic segment—its independent, entrepreneurial businesses.

Tech Tuesday: A.I. & Machine Learning

In this week’s Tech Tuesday, our friends at UF Innovate are joined Dr. Whitney Stoppel from UF’s Chemical Engineering Department. She discusses the department’s programs and its use of AI and machine learning in research.

ENTREPRENEURIAL HACK #13 | Courage, Failure & Resilience Go Hand in Hand

Let’s delve into the importance of using failure as an opportunity for growth, the value of testing new ideas despite uncertain outcomes, and the courage required to embrace and recover from failure.

Sparian Biosciences Awarded $19 Million Five-Year NIH/ NIDA Grant to Fund Development of SBS-518 for Stimulant Use Disorder Through Phase 1 Clinical Development

Sparian Biosciences, Inc., a clinical-stage CNS-focused biopharmaceutical company, announced it has been awarded a $19 million, five-year grant to fund the development of SBS-518 from IND submission through Phase 1 clinical development.

Oragenics, Inc. Announces Private Placement

Oragenics, a UF startup, is partnering with healthcare investors. They've privately placed 404,728 shares of common stock and 404,728 shares of Series E Mirroring Preferred Stock to fight infectious diseases, including coronaviruses.

Breakthrough Polymer Research Promises to Revolutionize Recycling

UF-led research makes major leap toward greener future.

UF Researchers Receive NCI Grant to Study microRNA Degradation in Acute Lymphoblastic Leukemia

A team of University of Florida researchers has received a five-year $2.5 million grant from the National Cancer Institute to study gene regulation in acute lymphoblastic leukemia (ALL).

Community Partners Band Together Against Homelessness, Fundraise for Grace Marketplace

The Tech Battle of the Bands scheduled for Aug. 18 at The Wooly hosted by startGNV, an organization supporting the growth of local tech companies. At the event, bands will compete in fundraising for GRACE Marketplace, a nonprofit and one-stop resource center for homelessness services in Gainesville.

UF Health Cancer Center Awards American Cancer Society Pilot Grants

The University of Florida Health Cancer Center has awarded the 2023 American Cancer Society Institutional Research Grant Pilot Projects, as part of its efforts to support early-stage investigators in cancer-related research studies. These projects, which are supported by Grant #21-139-01-IRG from the American Cancer Society, aim to address one of six research priorities: etiology, obesity/healthy eating and active living, screening and diagnosis, treatment, survivorship, and health equity across the cancer continuum.

UF News